Ken Ren, CEO and Director at CASI Pharmaceuticals, Inc. (CASI), bought 15,000 shares at $0.72 ($11K) on 2016-01-19, disclosed to the SEC on 2016-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.71 | 300 | $213 | 2.0% |
| 2 | $0.72 | 6,063 | $4K | 40.1% |
| 3 | $0.73 | 7,537 | $6K | 50.5% |
| 4 | $0.74 | 1,100 | $814 | 7.5% |
| Total | $0.73 avg | 15,000 | $11K | 100% |